Estrogen exerts neuroprotective effects on the brain, and the reduction in endogenous estrogen after menopause increases women’s risk for Alzheimer’s disease (AD), cerebrovascular disease, or both.
Use of menopausal hormone therapy is associated with an increased rate of dementia and Alzheimer's disease, suggests a large Danish study published by The BMJ. An increase was seen in long term users ...
A study of Danish women aged 50 – 60 reveals that continuous and cyclic menopausal hormone therapy can increase the risk of dementia and Alzheimer’s disease. The study is published in the British ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results